vs
Side-by-side financial comparison of Royalty Pharma plc (RPRX) and STANDARD MOTOR PRODUCTS, INC. (SMP). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $385.1M, roughly 1.6× STANDARD MOTOR PRODUCTS, INC.). Royalty Pharma plc runs the higher net margin — 34.4% vs 2.0%, a 32.4% gap on every dollar of revenue. On growth, STANDARD MOTOR PRODUCTS, INC. posted the faster year-over-year revenue change (12.2% vs 4.8%). Over the past eight quarters, STANDARD MOTOR PRODUCTS, INC.'s revenue compounded faster (7.8% CAGR vs 4.6%).
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Standard Motor Products, Inc. is a manufacturer and distributor of automotive parts. The company was founded in 1919 as a partnership by Elias Fife and Ralph Van Allen and incorporated by Fife in 1926. It is headquartered in Long Island City, New York, and trades on the New York Stock Exchange. SMP includes four operational segments: Vehicle Control, Temperature Control, Engineered Solutions and Nissens. SMP’s Vehicle Control and Temperature Control divisions supply automotive aftermarket com...
RPRX vs SMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $622.0M | $385.1M |
| Net Profit | $214.2M | $7.9M |
| Gross Margin | — | 31.7% |
| Operating Margin | 62.4% | 5.6% |
| Net Margin | 34.4% | 2.0% |
| Revenue YoY | 4.8% | 12.2% |
| Net Profit YoY | 2.9% | 457.9% |
| EPS (diluted) | $0.49 | $0.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $622.0M | $385.1M | ||
| Q3 25 | $609.3M | $498.8M | ||
| Q2 25 | $578.7M | $493.9M | ||
| Q1 25 | $568.2M | $413.4M | ||
| Q4 24 | $593.6M | $343.4M | ||
| Q3 24 | $564.7M | $399.3M | ||
| Q2 24 | $537.3M | $389.8M | ||
| Q1 24 | $568.0M | $331.4M |
| Q4 25 | $214.2M | $7.9M | ||
| Q3 25 | $288.2M | $-4.3M | ||
| Q2 25 | $30.2M | $25.2M | ||
| Q1 25 | $238.3M | $12.6M | ||
| Q4 24 | $208.2M | $-2.2M | ||
| Q3 24 | $544.0M | $3.8M | ||
| Q2 24 | $102.0M | $17.1M | ||
| Q1 24 | $4.8M | $8.8M |
| Q4 25 | — | 31.7% | ||
| Q3 25 | — | 32.4% | ||
| Q2 25 | — | 30.6% | ||
| Q1 25 | — | 30.2% | ||
| Q4 24 | — | 29.4% | ||
| Q3 24 | — | 30.4% | ||
| Q2 24 | — | 28.6% | ||
| Q1 24 | — | 27.0% |
| Q4 25 | 62.4% | 5.6% | ||
| Q3 25 | 70.1% | 9.5% | ||
| Q2 25 | 36.3% | 8.7% | ||
| Q1 25 | 94.0% | 5.9% | ||
| Q4 24 | 60.9% | 1.1% | ||
| Q3 24 | — | 9.3% | ||
| Q2 24 | 50.2% | 6.4% | ||
| Q1 24 | -13.0% | 4.4% |
| Q4 25 | 34.4% | 2.0% | ||
| Q3 25 | 47.3% | -0.9% | ||
| Q2 25 | 5.2% | 5.1% | ||
| Q1 25 | 41.9% | 3.0% | ||
| Q4 24 | 35.1% | -0.6% | ||
| Q3 24 | 96.3% | 1.0% | ||
| Q2 24 | 19.0% | 4.4% | ||
| Q1 24 | 0.8% | 2.7% |
| Q4 25 | $0.49 | $0.34 | ||
| Q3 25 | $0.67 | $-0.19 | ||
| Q2 25 | $0.07 | $1.13 | ||
| Q1 25 | $0.55 | $0.56 | ||
| Q4 24 | $0.46 | $-0.09 | ||
| Q3 24 | $1.21 | $0.17 | ||
| Q2 24 | $0.23 | $0.77 | ||
| Q1 24 | $0.01 | $0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $618.7M | — |
| Total DebtLower is stronger | $9.0B | $618.7M |
| Stockholders' EquityBook value | $9.7B | $683.7M |
| Total Assets | $19.6B | $2.0B |
| Debt / EquityLower = less leverage | 0.92× | 0.90× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $618.7M | — | ||
| Q3 25 | $938.9M | $87.2M | ||
| Q2 25 | $631.9M | $58.8M | ||
| Q1 25 | $1.1B | $50.3M | ||
| Q4 24 | $929.0M | $44.4M | ||
| Q3 24 | $950.1M | $26.3M | ||
| Q2 24 | $1.8B | $26.2M | ||
| Q1 24 | $843.0M | $27.1M |
| Q4 25 | $9.0B | $618.7M | ||
| Q3 25 | $8.9B | $589.5M | ||
| Q2 25 | $8.0B | $636.6M | ||
| Q1 25 | $7.6B | $650.6M | ||
| Q4 24 | $7.6B | $562.3M | ||
| Q3 24 | $7.6B | $142.8M | ||
| Q2 24 | $7.6B | $208.2M | ||
| Q1 24 | $6.1B | $214.9M |
| Q4 25 | $9.7B | $683.7M | ||
| Q3 25 | $9.6B | $677.4M | ||
| Q2 25 | $9.5B | $688.6M | ||
| Q1 25 | $9.8B | $638.0M | ||
| Q4 24 | $10.3B | $615.7M | ||
| Q3 24 | $10.3B | $638.8M | ||
| Q2 24 | $9.8B | $640.0M | ||
| Q1 24 | $9.9B | $639.1M |
| Q4 25 | $19.6B | $2.0B | ||
| Q3 25 | $19.3B | $2.0B | ||
| Q2 25 | $18.3B | $2.0B | ||
| Q1 25 | $17.6B | $1.9B | ||
| Q4 24 | $18.2B | $1.8B | ||
| Q3 24 | $18.0B | $1.4B | ||
| Q2 24 | $17.7B | $1.4B | ||
| Q1 24 | $16.1B | $1.4B |
| Q4 25 | 0.92× | 0.90× | ||
| Q3 25 | 0.93× | 0.87× | ||
| Q2 25 | 0.84× | 0.92× | ||
| Q1 25 | 0.78× | 1.02× | ||
| Q4 24 | 0.74× | 0.91× | ||
| Q3 24 | 0.74× | 0.22× | ||
| Q2 24 | 0.78× | 0.33× | ||
| Q1 24 | 0.62× | 0.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $827.1M | $-28.2M |
| Free Cash FlowOCF − Capex | — | $-37.6M |
| FCF MarginFCF / Revenue | — | -9.8% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 3.86× | -3.59× |
| TTM Free Cash FlowTrailing 4 quarters | — | $18.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $827.1M | $-28.2M | ||
| Q3 25 | $702.6M | $91.6M | ||
| Q2 25 | $364.0M | $54.3M | ||
| Q1 25 | $596.1M | $-60.2M | ||
| Q4 24 | $742.5M | $-1.5M | ||
| Q3 24 | $703.6M | $88.3M | ||
| Q2 24 | $658.2M | $35.6M | ||
| Q1 24 | $664.6M | $-45.7M |
| Q4 25 | — | $-37.6M | ||
| Q3 25 | — | $81.5M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $-69.4M | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | — | $77.1M | ||
| Q2 24 | — | $22.7M | ||
| Q1 24 | — | $-55.8M |
| Q4 25 | — | -9.8% | ||
| Q3 25 | — | 16.3% | ||
| Q2 25 | — | 8.9% | ||
| Q1 25 | — | -16.8% | ||
| Q4 24 | — | -3.3% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | — | -16.8% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | 3.86× | -3.59× | ||
| Q3 25 | 2.44× | — | ||
| Q2 25 | 12.06× | 2.15× | ||
| Q1 25 | 2.50× | -4.79× | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | 1.29× | 23.19× | ||
| Q2 24 | 6.45× | 2.09× | ||
| Q1 24 | 139.10× | -5.18× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
SMP
| Engineered Solutions | $66.1M | 17% |
| Electrical And Safety | $63.6M | 17% |
| Temperature Control | $61.5M | 16% |
| Europe Excluding Poland | $55.5M | 14% |
| Other Thermal Components | $30.7M | 8% |
| Air Conditioning | $22.7M | 6% |
| Commercial Vehicle | $19.7M | 5% |
| All Other | $18.9M | 5% |
| PL | $16.0M | 4% |
| Wire Sets And Other | $11.9M | 3% |
| Engine Efficiency | $10.0M | 3% |
| Construction Agriculture | $7.8M | 2% |
